Good afternoon, ladies and gentlemen, and welcome to Zumiez Inc. Fourth Quarter Fiscal 2025 Earnings Conference Call. [Operator Instructions] Before we begin, I'd like to remind everyone of the ...
Deep dive on the heavy-truck demand slump, orders rebound, profitability plans, and 2026 outlook amid diesel/geopolitics—read ...
15h
Build-A-Bear Workshop Reports Fourth and Record Fiscal 2025 Results; Increases Quarterly Dividend
Bear Workshop, Inc. (NYSE: BBW) today announced results for the fourth quarter of fiscal year 2025 ended January 31, 2026.
Radio broadcasting net revenue -- $35.1 million, a 26.5% decline year over year; local ad sales fell 19% while national ad sales were down 40.1%. Reach Media net revenue -- $13.8 million, up 43.9%, ...
Earnings call Ulta Beauty posted Q4 net sales growth of 11.8% YoY to $3.9B and FY25 sales up 9.7% to $12.4B, surpassing guidance. Operating profit and EPS both exceeded expectations. For FY26, Ulta ...
Here Group Limited (NASDAQ: HERE) ('Here” or the 'Company”), an IP1-based pop toy company dedicated to creating beloved collectibles and trend-defining experiences, today announced its unaudited ...
SCOTTSDALE, Ariz., March 12, 2026 (GLOBE NEWSWIRE)-- The Joint Corp. (NASDAQ: JYNT) (the "Company”), a national operator, manager, and franchisor of chiropractic clinics, reported financial results ...
Record Quarterly and Annual Revenues, Up 48.4% and 11.7% Year-Over-Year, RespectivelyFirst GAAP Profitable Quarter; Adjusted Net Income1 (Non-GAAP) Up 96.4% Year-Over-YearNon-GAAP Profitability1 Achie ...
Here Group Limited (NASDAQ: HERE) ("Here" or the "Company"), an IP1-based pop toy company dedicated to creating beloved collectibles and trend-defining experiences ...
Detailed price information for First Watch Restaurant Group Inc (FWRG-Q) from The Globe and Mail including charting and trades.
CNW/ - Ascend Wellness Holdings, Inc. ("AWH," "Ascend," or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated ...
Reported Promising Data for TN-201 and TN-401 Gene Therapies in Fourth Quarter of 2025; Additional Data Readouts and Pursuit of Regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results